Air Bubble in Your Mounjaro Pen: What the Guidance Actually Says

What the manufacturer's guidance and clinical evidence tell us about bubbles in pre-filled pens

The Mounjaro SmPC and patient information leaflet, published on the electronic Medicines Compendium, describe the KwikPen as a pre-filled, pre-dosed device. Unlike insulin drawn from a vial, the pen does not require a user-performed air-purge or 'air shot' before injection. This distinction matters: the air-purge step exists in vial-and-syringe technique specifically because drawing medication into a syringe inevitably introduces air that can displace part of the dose. A factory-filled pen has already accounted for the small amount of air that sits naturally in any sealed liquid chamber.

Subcutaneous injections (the type used for Mounjaro) are well-established in clinical practice for a wide range of medicines including insulin, low-molecular-weight heparins and GLP-1 receptor agonists. The subcutaneous tissue absorbs small volumes of air without adverse effect; this is one of the reasons subcutaneous injections carry a different air-bubble risk profile compared with intravenous administration, where air can reach the bloodstream directly. The NHS tirzepatide patient page reinforces this by directing users to follow the pen's instructions for use without any additional priming steps.

In the SURMOUNT-1 trial (which randomised 2,539 adults across tirzepatide doses and assessed outcomes over 72 weeks) pen usability and tolerability were monitored as secondary measures. No signal emerged linking small trapped air to dose inaccuracy or local reactions, consistent with what pre-clinical device validation would predict. The takeaway: if you notice air bubbles in your Mounjaro pen, they are a feature of the product, not a flaw in it.

Why trying to remove the bubble can do more harm than good

This is a question our prescribers hear most weeks, and the answer is almost always the same: leave it alone. When a patient taps the pen and presses the plunger to push air out, they are also pushing tirzepatide solution out. Each Mounjaro KwikPen contains a single four-week supply at the prescribed strength. There is no 'spare' liquid engineered in for purging. Losing even a small amount of solution before the injection means the dose you receive is lower than intended.

The mechanics of the KwikPen make this particularly easy to do by accident. The device is spring-loaded; a partial press to expel a bubble can release the mechanism and deliver liquid into the air rather than into your tissue. If you are unsure what you're seeing inside the pen, our guide to the Mounjaro KwikPen walks through the window, plunger and needle components in plain terms.

Correct technique is to attach a fresh needle, choose your injection site, clean the skin with an alcohol swab, pinch the tissue if instructed in your leaflet, press the pen firmly against the skin and hold it there for the count specified in your instructions for use. The pen clicks and delivers the full dose. If you spot a bubble in your Mounjaro pen before the injection, it is irrelevant to what enters your body, because the liquid fills the needle path and the air remains behind in the chamber.

For site selection (abdomen, thigh or upper arm are the licensed options) this overview of the Mounjaro injection process covers rotation and technique in detail. Rotating sites each week reduces tissue build-up and keeps absorption consistent.

When a bubble is actually a reason to stop and check

Most bubbles in a Mounjaro pen are tiny, clear and inconsequential. There are a small number of situations where pausing makes sense before you proceed.

A bubble that takes up more than roughly a third of the visible liquid window may suggest the pen has been dropped and the cartridge seal disturbed, or that significant liquid has already escaped. Inspect the pen for cracks. If the liquid looks cloudy, has visible particles floating in it, or has changed colour, do not use it. Tirzepatide solution should be clear to slightly yellow and particle-free. These checks are described in the Mounjaro SmPC on the eMC under the visual inspection step.

Storage issues can also affect what you see. Mounjaro must be kept refrigerated at 2–8°C; if a pen has been left at room temperature for longer than the window specified in your leaflet, or has been frozen, the solution may be compromised. The exact room-temperature limit is stated in the patient information leaflet, always check there rather than relying on a general figure, because storage windows can be updated.

If you are ever uncertain whether a pen is fit to use, the safest move is not to inject and to contact your prescriber or pharmacy. At nume, the aftercare team is available seven days a week. Get in touch if something about your pen doesn't look right and you want a clinical opinion before proceeding.

Needles should be changed for every injection; a used or blunted needle can affect how smoothly the pen delivers and may introduce additional air. Compatible replacement needles are available from our pharmacy if you need them. Once you've finished with a used needle, dispose of it safely in a sharps container rather than the household bin.

For a broader look at what Mounjaro involves (eligibility, how it works clinically, and what to expect across the dose schedule) our Mounjaro overview covers the full picture. And if you're comparing injection sites or thinking about whether the gluteal area is an option, that's addressed separately.

Mounjaro is a prescription-only medicine. If you haven't yet started treatment and want to understand whether it's clinically appropriate for you, a free consultation with one of our GPhC-registered prescribers is the right starting point. They review every application personally, the same day.